Zhejiang Garden Biopharmaceutical Hits Day Low Amid Price Pressure at CNY 13.20

Zhejiang Garden Biopharmaceutical Co., Ltd. experienced a notable decline in its stock performance today, with shares dropping by 5.02% as of March 23, 2026. The stock reached an intraday low of CNY 13.20, reflecting ongoing challenges in the market. Over the past week, the stock has seen a significant decrease of 16.06%, while its performance over the last month has declined by 21.09%. In a broader context, the stock has underperformed compared to the China Shanghai Composite, which has shown a decline of 6.65% over the same week and 6.58% over the past month. Looking at longer-term trends, Zhejiang Garden Biopharmaceutical has reported a 9.26% decrease over the past year, contrasting sharply with the 13.33% gain of the China Shanghai Composite. The company's market capitalization stands at CNY 9,033 million, with a price-to-earnings ratio of 24.00 and a dividend yield of 0.70%. Despite its midcap status, the stock's performance metrics indicate a challenging environment for the company within the pharmaceuticals and biotechnology sector.